Potential teratogenicity of methimazole: Exposure of zebrafish embryos to methimazole causes similar developmental anomalies to human methimazole embryopathy

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 98, Issue 3, 2013, Pages 222-229

  Komoike, Yuta ^a   Matsuoka, Masato ^a   Kosaki, Kenjiro ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Maternal exposure; Methimazole; Zebrafish

Indexed keywords

THIAMAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY SURFACE; BRAIN DEVELOPMENT; BRAIN HYPOPLASIA; CELL DEATH; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; DISEASE SEVERITY; DRUG EXPOSURE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOPATHY; ESOPHAGUS MALFORMATION; FERTILIZATION; FOREBRAIN; HYPOPLASIA; NERVOUS SYSTEM; NEURAL TUBE DEFECT; NONHUMAN; NOTOCHORD; PHARYNX DISEASE; PIGMENT DISORDER; PRIORITY JOURNAL; RETINA DISEASE; RHOMBENCEPHALON; TERATOGENICITY;

ANIMALS; APOPTOSIS; BRAIN; EMBRYO, NONMAMMALIAN; ENVIRONMENTAL EXPOSURE; ESOPHAGUS; FETAL DISEASES; HUMANS; METHIMAZOLE; NOTOCHORD; PHARYNX; RETINA; SPINAL CORD; TERATOGENS; ZEBRAFISH;

DANIO RERIO;

EID: 84878981162     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.21057     Document Type: Article

References (40)

1. Albee RR, Mattsson JL, Johnson KA, Kirk HD, Breslin WJ. 1989. Neurological consequence of congenital hypothyroidism in Fischer 344 rats. Neurotoxicol Teratol 11:171-183.
2. Aramaki M, Hokuto I, Matsumoto T, Ishimoto H, Inoue M, Kimura T, Oikawa Y, Ikeda K, Yoshimura Y, Takahashi T, Kosaki K. 2005. Iridic and retinal coloboma associated with prenatal methimazole exposure. Am J Med Genet 139A:156-158.
3. Brown D. 1997. The role of thyroid hormone in zebrafish and axolotl development. Proc Natl Acad Sci USA 94:13011-13016.
4. Cassina M, Donà M, Di Gianantonio E, Clementi M. 2012. Pharmacologic treatment of hyperthyroidism during pregnancy. Birth Defects Res A 94:612-619.
5. Chattaway JM, Klepser TB. 2007. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy. Ann Pharmacother 41:1018-1022.
6. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. 1999. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83:43-46.
7. Comer CP, Norton S. 1982. Effects of perinatal methimazole exposure on a developmental test battery for neurobehavioral toxicity in rats. Toxicol Appl Pharmacol 63:133-141.
8. Devoto SH, Melançon E, Eisen JS, Westerfield M. 1996. Identification of separate slow and fast muscle precursor cells in vivo, prior to somite formation. Development 122:3371-3380.
9. Diav-Citrin O, Ornoy A. 2002. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology 65:38-44.
10. Dong C, Zhang Y, Guo L, Li QM. 2010. Spectrophotometric determination of methimazole in pharmaceutical, serum and urine samples by reaction with potassium ferricyanide-Fe(III). J Anal Chem 65:707-712.
11. Ebrahimzadeh H, Asgharinezhad AA, Adlnasab L, Shekari N. 2012. Optimization of ion-pair based hollow fiber liquid phase microextraction combined with HPLC-UV for the determination of methimazole in biological samples and animal feed. J Sep Sci 35:2040-2047.
12. Elsalini O, Rohr K. 2003. Phenylthourea disrupts thyroid function in developing zebrafish. Dev Genes Evol 212:593-598.
13. Floberg S, Lanbeck K, Lindström B. 1980. Determination of methimazole in plasma using gas chromatography-mass spectrometry after extractive alkylation. J Chromatogr 182:63-70.
14. Greenberg F. 1987. Choanal atresia: methimazole teratogenicity or a new syndrome? Am J Med Genet 28:931-934.
15. Hanlon DP, Shuman S. 1975. Copper ion binding and enzyme inhibitory properties of the antithyroid drug methimazole. Experientia 31:1005-1006.
16. Holley SA, Nüsslein-Volhard C. 2000. Somitogenesis in zebrafish. Curr Top Dev Biol 47:247-277.
17. Jansson R, Lindström B, Dahlberg PA. 1985. Pharmacokinetic properties and bioavailability of methimazole. Clin Pharmacokinet 10:443-450.
18. Karlsson J, von Hofsten J, Olsson PE. 2001. Generating Transparent Zebrafish: a refined method to improve detection of gene expression during embryonic development. Mar Biotechnol 3:522-527.
19. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. 1995. Stages of embryonic development of the zebrafish. Dev Dyn 203:253-310.
20. Liu YY, Chan WK. 2002. Thyroid hormones are important for embryonic to larval transitory phase in zebrafish. Differentiation 70:36-45.
21. Lun K, Brand M. 1998. A series of no isthmus (noi) alleles of the zebrafish pax2.1 gene reveals multiple signaling event in development of the midbrain-hindbrain boundary. Development 125:3049-3062.
22. Luna LG. 1968. Manual of histologic staining methods of the Armed Forces Institute of Pathology. New York: Blakiston Division, McGraw-Hill.
23. Mandel SJ, Brent GA, Larsen PR. 1994. Review of antithyroid drug use during pregnancy and a report of a case of aplasia cutis. Thyroid 4:129-133.
24. Milham S, Jr., Elledge W. 1972. Maternal methimazole and congenital defects in children [letter]. Teratology 5:125-126.
25. Millott N, Lynn WG. 1966. Ubiquity of melanin and the effect of phenylthiourea. Nature 209:99-101.
26. Momotani N, Noh JY, Ishikawa N, Ito K. 1997. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 82:3633-3636.
27. Ramírez A, Espinosa de los Monteros A, Parra A, De León B. 1992. Esophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid women receiving methimazole (Tapazol) during pregnancy. Am J Med Genet 44:200-202.
28. Rice SA, Millan DP, West JA. 1987. The behavioral effects of perinatal methimazole administration in Swiss Webster mice. Fundam Appl Toxicol 8:531-540.
29. Sakamoto T, Kondo K, Kashio A, Suzukawa K, Yamasoba T. 2007. Methimazole-induced cell death in rat olfactory receptor neurons occurs via apoptosis triggered through mitochondrial cytochrome c-mediated caspase-3 activation pathway. J Neurosci Res 85: 548-557.
30. Shikii A, Izumi T, Uehara T, Fukuyama Y. 1989. A case of hydrops fetalis, minor anomalies and symptomatic West syndrome born to a mother with Basedow disease and thiamazole treatment. Teratology 40:663.
31. Stanisstreet M, Herbert LC, Pharoah PO. 1990. Effects of thyroid antagonists on rat embryos cultured in vitro. Teratology 41:721-729.
32. Stickney HL, Barresi MJ, Devoto SH. 2000. Somite development in zebrafish. Dev Dyn 219:287-303.
33. Sun J, Zheng C, Xiao X, Niu L, You T, Wang E. 2005. Electrochemical detection of methimazole by capillary electrophoresis at a carbon fiber microdisk electrode. Electroanalysis 17:1675-1680
34. van Eeden FJ, Granato M, Schach U, Brand M, Furutani-Seiki M, Haffter P, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Kelsh RN, Mullins MC, Odenthal J, Warga RM, Allende ML, Weinberg ES, Nüsslein-Volhard C. 1996. Mutations affecting somite formation and patterning in the zebrafish, Danio rerio. Development 123:153-164.
35. Wasch KD, Brabander HF, Impens S, Vandewiele M, Courtheyn D. 2001. Determination of mercaptobenzimidazol and other thyreostat residues in thyroid tissue and meat using high-performance liquid chromatography-mass spectrometry. J Chromatogr A 912:311-317.
36. Wendl T, Lun K, Mione M, Favor J, Brand M, Wilson SW, Rohr KB. 2002. pax2.1 is required for the development of thyroid follicles in zebrafish. Development 129:3751-3760.
37. Whittaker JR. 1966. An analysis of melanogenesis in differentiating pigment cells of ascidian embryos. Dev Biol 14:1-39.
38. Wilson LC, Kerr BA, Wilkinson R, Fossard C, Donnai D. 1998. Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Am J Med Genet 75:220-222.
39. Zakrzewski R. 2008. Determination of methimazole in urine with the iodine-azide detection system following its separation by reversed-phase high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 869:67-74.
40. Zolcinski A, Heinrath T, Rzucidlo Z. 1964. Effect of methimazole on development of rabbit fetuses. Gynekol Pol 35:593-596.